PFE.BA

Pfizer Inc. operates as a leading global biopharmaceutical company, overseeing the entire lifecycle of its medicinal products—from initial discovery and rigorous development to worldwide manufacturing, strategic marketing, and extensive distribution. Its comprehensive product portfolio addresses a vast array of health challenges. Key therapeutic areas include cardiovascular metabolic disorders, migraines, and women's health, featuring prominent brands such as Eliquis, Nurtec ODT/Vydura, and the Premarin family. The company actively develops and supplies treatments for infectious diseases, particularly those with critical unmet medical needs, exemplified by the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba. A major focus is on global health threats like COVID-19, offering both preventive vaccines and treatments under the Comirnaty and Paxlovid brands, alongside ongoing development of future mRNA and antiviral therapies. Pfizer also provides a range of biosimilars for chronic immune and inflammatory conditions, including Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo. Its specialized medicines extend to rare diseases such as amyloidosis, hemophilia, endocrine disorders, and sickle cell disease, with brands like the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin. The company's offerings further encompass sterile injectable and anti-infective medications, including Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga, as well as advanced biologics, small molecules, immunotherapies, and biosimilars such as Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi. Beyond its proprietary drugs, Pfizer engages in contract manufacturing services. Its extensive customer base spans wholesalers, retailers, hospitals, clinics, government agencies, individual healthcare provider offices, retail pharmacies, integrated delivery systems, and disease control and prevention centers globally. The company has forged significant collaboration agreements with entities like Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Merck KGaA, Valneva SE, BioNTech SE, and Arvinas, Inc. Noteworthy partnerships include a strategic alliance with CSPC Pharmaceutical Group Limited to launch a localized COVID-19 oral therapeutic treatment (Nirmatrelvir/Ritonavir) in China, and a collaboration with Carrick Therapeutics Limited. Founded in 1849, Pfizer Inc. is headquartered in New York, New York.